ELTP

Elite Pharmaceuticals (QB) Stock Price

0.055
0.0025 (4.76%)
0.055
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Elite Pharmaceuticals Inc (QB) ELTP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0025 4.76% 0.055 12:51:46
Open Price Low Price High Price Close Price Previous Close
0.0535 0.053 0.056 0.0525
Bid Price Ask Price Spread News
0.053 0.055 0.002 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
31 312,910 $ 0.05481 $ 17,151 977,385 0.048 - 0.115
Last Trade Time Type Quantity Stock Price Currency
12:52:05 600 $ 0.055 USD

Elite Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.50M 1.01B 793.80M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
86.71k $ - 0.00% - -

more financials information »

Elite Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0550.0570.0480.05380182,204,7810.000.0%
1 Month0.06180.090.0480.05886112,267,347-0.0068-11.0%
3 Months0.07250.090.0480.06102341,031,474-0.0175-24.14%
6 Months0.08370.09950.0480.0690566945,856-0.0287-34.29%
1 Year0.08640.1150.0480.0785175937,330-0.0314-36.34%
3 Years0.09150.1450.03330.0862851800,951-0.0365-39.89%
5 Years0.36030.420.03330.1488403949,815-0.3053-84.73%

Elite Pharmaceuticals (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and packaging of niche generic products, which are then distributed by exclusive marketing partners. Elite specializes in oral sustained and controlled release drug products that have high barriers to entry. Elite owns generic products which have been licensed to TAGI Pharma, Glenmark Pharmaceuticals, Inc., USA., and Lannett Company, Inc. Elite currently has eleven approved generic products, two which are pending launch, another two generic products are filed with the FDA, and an NDA filed for SequestOx(TM). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.


Your Recent History
USOTC
ELTP
Elite Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.